Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Edema and APOE[original query] |
---|
The epsilon4 allele of apolipoprotein E gene is a potential risk factor for the severity of macular edema in type 2 diabetic Mexican patients. Ophthalmic genetics 2002 Mar 23 (1): 13-9. Santos Arturo, Salguero Mario L, Gurrola Carmen, Muñoz Francisco, Roig-Melo Enrique, Panduro Artu |
Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humans. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 0 18 (2): 144-9. James Michael L, Blessing Robert, Bennett Ellen, Laskowitz Daniel |
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study. Dementia and geriatric cognitive disorders 2010 30 (2): 131-46. Gold Michael, Alderton Claire, Zvartau-Hind Marina, Egginton Sally, Saunders Ann M, Irizarry Michael, Craft Suzanne, Landreth Gary, Linnamägi Ulla, Sawchak Shar |
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies. Current Alzheimer research 2011 Aug 8 (5): 592-606. Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders A M, Irizarry M, Jeter B, Zvartau-Hind M, van Dyck C H, Gold |
Amyloid-Related Imaging Abnormalities in Clinical Trials of Gantenerumab in Early Alzheimer Disease. JAMA neurology 2024 11 . Stephen Salloway, Jakub Wojtowicz, Nicola Voyle, Christopher A Lane, Gregory Klein, Marco Lyons, Simona Rossomanno, Francesca Mazzo, Szofia Bullain, Frederik Barkhof, Tobias Bittner, Andres Schneider, Michael Grundman, Roxana Aldea, Mercè Boada, Janice Smith, Rachelle Doo |
- Page last reviewed:Feb 1, 2024
- Content source: